Home > Press > Raymor Makes First Payment to Creditors and Seeks Court Approval to Hold Shareholders Meeting No Later Than October 15, 2009
Abstract:
Raymor Industries Inc. (TSX VENTURE:RAR), a leading developer and producer of single-walled carbon nanotubes, nanomaterials and advanced materials confirms that it will be seeking court approval to hold its Annual and Special Meeting of Shareholders no later than October 15, 2009. At this meeting, Raymor proposes to present to its shareholders the Audited Financial Statements for 2007 and 2008. In this regard, the Company expects to be in position to file its audited consolidated financial statements for the years ended December 31, 2008 and 2007 and its interim unaudited consolidated financial statements for the first and second quarter ended March 31, 2009 and June 30, 2009 respectively, no later than August 15, 2009.
With the recent changes in the management of the Company, Raymor's Board of Directors is continuing their work in realizing the Restructuring Plan for the Company. In addition, the Company has made the first payment to its creditors pursuant to the terms of its Proposal to its creditors.
The shares of Raymor have been halted on the TSX Venture Exchange and are the subject of a cease-trade order from the securities regulators.
Caution regarding forward-looking statements:
Certain statements contained in this release contain forward-looking statements. When used in this document, the words "may", "would", "could", "will", "intend", "plan", "anticipate", "believe", "estimate", "expect" and similar expressions may be used to identify forward-looking statements. Those statements reflect Raymor's current views with respect to future events or conditions, including prospective results of operations, financial position, and predictions of future actions, plans or strategies. Certain material factors and assumptions were applied in drawing Raymor's conclusions and making those forward looking statements. By their nature, those statements reflect management's current views, beliefs and assumptions and are subject to certain risks and uncertainties, known and unknown, including, without limitation, the possibility that Raymor may not satisfy all conditions to obtain the final approval of the Exchange in connection with the offering, including allowing the issuance of common shares in lieu of cash payment of interest, the timing of filing of the Raymor's audited financial statements, MD&A and related CEO and CFO certifications for the year ended December 31, 2008 and for the first quarter ended March 31, 2009, and the timing of filing of default status reports. Many factors could cause Raymor's actual results, performance or achievements to be materially different from any future results.
ON BEHALF OF THE BOARD OF DIRECTORS
Rolland Veilleux, Chairman of the Board of Directors (tel: 450-434-1004).
"Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release."
####
For more information, please click here
Contacts:
Raymor Industries Inc.
Investor Relations
450-434-1004
450-434-1200 (FAX)
Copyright © Marketwire
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Legal
180 Degree Capital Corp. Issues Open Letter to the Board and Shareholders of Enzo Biochem, Inc. February 4th, 2021
Nanogate: Meeting of creditors on November 4, 2020 September 4th, 2020
SUNY CNSE and Albany Law School Partner to Create First-of-its-Kind Nanotechnology Education and Training Program November 5th, 2013
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Nanotubes/Buckyballs/Fullerenes/Nanorods/Nanostrings
Tests find no free-standing nanotubes released from tire tread wear September 8th, 2023
Detection of bacteria and viruses with fluorescent nanotubes July 21st, 2023
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||